Literature DB >> 24141347

A FRAX model for the estimation of osteoporotic fracture probability in Portugal.

Andréa Marques, António Mota, Helena Canhão, José Carlos Romeu, Pedro Machado, Afonso Ruano, Ana Paula Barbosa, António Aroso Dias, Daniel Silva, Domingos Araújo, Eugénia Simões, Fernanda Aguas, Inês Rosendo, Inês Silva, Jorge Crespo, José Delgado Alves, Lúcia Costa, Mário Mascarenhas, Óscar Lourenço, Pedro Lopes Ferreira, Raquel Lucas, Raquel Roque, Jaime Cunha Branco, Viviana Tavares, Helena Johansson, Jonh Kanis, José António Pereira da Silva.   

Abstract

INTRODUCTION: The objective of this study was to develop a Portuguese version of the World Health Organization fracture risk assessment tool (FRAX®).
METHODS: All cases of hip fracture occurred at or after 40 years of age were extracted from the Portuguese National Hospital Discharge Register from 2006 to 2010. Age and sex-ranked population estimates and mortality rates were obtained from National Statistics. Age- and gender stratified incidences were computed and the average of the five years under consideration was taken. Rates for other major fractures were imputed from the epidemiology of Sweden, as undertaken for most national FRAX® models. All methodological aspects and results were submitted to critical appraisal by a wide panel of national experts and representatives of the different stakeholders, including patients.
RESULTS: Hip fracture incidence rates were higher in women than in men and increased with age. The lowest incidence was observed in 40-44 years group (14.1 and 4.0 per 100,000 inhabitants for men and women, respectively). The highest rate was observed among the 95-100 age-group (2,577.6 and 3,551.8/100,000 inhabitants, for men and women, respectively). The estimated ten-year probability for major osteoporotic fracture or hip fracture increased with decreasing T-score and with increasing age.
CONCLUSIONS: Portugal has one of the lowest fracture incidences among European countries. The FRAX® tool has been successfully calibrated to the Portuguese population, and can now be used to estimate the ten-year risk of osteoporotic fractures in this country. All major stakeholders officially endorsed the Portuguese FRAX® model and co-authored this paper.

Entities:  

Mesh:

Year:  2013        PMID: 24141347

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  4 in total

1.  Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression.

Authors:  Joana Caetano-Lopes; Ana Rodrigues; Ana Lopes; Ana C Vale; Michael A Pitts-Kiefer; Bruno Vidal; Inês P Perpétuo; Jacinto Monteiro; Yrjö T Konttinen; Maria F Vaz; Ara Nazarian; Helena Canhão; João E Fonseca
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

2.  The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.

Authors:  A Marques; Ó Lourenço; J A P da Silva
Journal:  Osteoporos Int       Date:  2015-05-19       Impact factor: 4.507

Review 3.  A brief history of FRAX.

Authors:  John A Kanis; Helena Johansson; Nicholas C Harvey; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2018-10-31       Impact factor: 2.617

4.  Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study.

Authors:  Andréa Marques; Raquel Lucas; Eugénia Simões; Suzanne M M Verstappen; Johannes W G Jacobs; Jose A P da Silva
Journal:  RMD Open       Date:  2017-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.